| Title |
Molecular Adjuvants Based on Nonpyrogenic Lipophilic Derivatives of norAbuMDP/GMDP Formulated in Nanoliposomes: Stimulation of Innate and Adaptive Immunity
|
|---|---|
| Published in |
Pharmaceutical Research, January 2015
|
| DOI | 10.1007/s11095-014-1516-y |
| Pubmed ID | |
| Authors |
Pavlína Turánek Knotigová, Daniel Zyka, Josef Mašek, Anna Kovalová, Michal Křupka, Eliška Bartheldyová, Pavel Kulich, Štěpán Koudelka, Róbert Lukáč, Zuzana Kauerová, Antonín Vacek, Milada Stuchlová Horynová, Alois Kozubík, Andrew D. Miller, Ladislav Fekete, Irena Kratochvílová, Jan Ježek, Miroslav Ledvina, Milan Raška, Jaroslav Turánek |
| Abstract |
The aim of this work was to demonstrate an immunostimulatory and adjuvant effect of new apyrogenic lipophilic derivatives of norAbuMDP and norAbuGMDP formulated in nanoliposomes. |
X Demographics
The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 1 | 100% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 1 | 100% |
Mendeley readers
The data shown below were compiled from readership statistics for 28 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 28 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Ph. D. Student | 10 | 36% |
| Student > Master | 6 | 21% |
| Researcher | 3 | 11% |
| Professor | 1 | 4% |
| Student > Doctoral Student | 1 | 4% |
| Other | 2 | 7% |
| Unknown | 5 | 18% |
| Readers by discipline | Count | As % |
|---|---|---|
| Chemistry | 6 | 21% |
| Agricultural and Biological Sciences | 3 | 11% |
| Medicine and Dentistry | 3 | 11% |
| Biochemistry, Genetics and Molecular Biology | 2 | 7% |
| Pharmacology, Toxicology and Pharmaceutical Science | 2 | 7% |
| Other | 5 | 18% |
| Unknown | 7 | 25% |
Attention Score in Context
This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 17 December 2015.
All research outputs
#20,251,805
of 22,780,967 outputs
Outputs from Pharmaceutical Research
#2,643
of 2,856 outputs
Outputs of similar age
#296,962
of 353,036 outputs
Outputs of similar age from Pharmaceutical Research
#33
of 37 outputs
Altmetric has tracked 22,780,967 research outputs across all sources so far. This one is in the 1st percentile – i.e., 1% of other outputs scored the same or lower than it.
So far Altmetric has tracked 2,856 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.0. This one is in the 1st percentile – i.e., 1% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 353,036 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 37 others from the same source and published within six weeks on either side of this one. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.